Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
Dr Jeffrey Bradstreet, whose body was found floating in a North Carolina river on June 19, had successfully treated over 2,000 autistic children with GcMAF.
Motive to murder medical researchers and suppress a promising cancer treatment breakthrough
INVESTIGATION: Here's what we know so far
Both U.S. and UK governments desperately seizing all supply, shutting down clinics, even as millions die from cancer every decade...
GcMAF (Gc Protein derived Macrophage Activating Factor) - Gc MAF treatment is a highly effective macrophage activating therapy, used to stimulate the immune system and activate macrophages so that they can destroy cancer cells and other abnormal cells in the body.
From the FAQ page of the treatment clinic:
What exactly is Second Generation GcMAF?
High Dose Second Generation Gc-MAF is produced using our new Patent Pending process which was developed here in Japan by Saisei Mirai in collaboration with Dr Hitoshi Hori and Dr Yoshihiro Uto at the University of Tokushima who have been studying GcMAF for over 20 years. Studies on GcMAF began at the University of Tokushima in 1992, after they were introduced to Dr Nobuto Yamamoto's work and a collaboration began...
Second Generation GcMAF is made using a new and improved 2nd generation method of Gc-MAF production which is 10-20 times more concentrated and is more active and stable than other GcMAF that is currently available. Importantly, this much higher concentration GcMAF has been clinically demonstrated to be largely free of any side effects in the great majority of patients and is much more stable because it is resistant to oxidation.
That same site describes Oral GcMAF as follows: "Oral GcMAF is a form of GcMAF produced from bovine colostrum by Saisei Mirai which was developed in collaboration with Tokushima University."
It also lists the following health conditions as being treatable with GcMAF, potentially a "universal cancer cure" substance:
Gc-MAF and/or oral Colostrum MAF macrophage activation therapy is indicated in the treatment of any diseases where there is immune dysfunction or where the immune system is compromised, such as:
- Autoimmune diseases
- Epstein-Barr Virus (EBV)
- Hepatitis B virus (HBV)
- Herpes Simplex virus (HSV)
- Hepatitis C virus (HCV)
- Multiple sclerosis (MS)
- Urinary tract infection (UTI)
- Autism Spectrum Disorders (ASD)
- Rheumatoid arthritis (RA)
- Chronic Fatigue Syndrome (CFS)
- Lyme disease (Lyme borreliosis)
- IgA deficiency disorder
- Myalgic Encephalomyelitis (ME)
- Mycobacteria infections
- Parkinson's disease
- Human papillomavirus (HPV)
- Lupus (Systemic lupus erythematosus, SLE)
- HIV AIDS
- Dengue fever
- Pneumonia infection
- Warts caused by viral infection
- Malaria Influenza virus (flu)
- Herpes simplex virus (HSV)
- Q fever (Coxiella burnetii)
- Polycystic ovary syndrome (PCOS)
- Chicken pox (varicella zoster virus)
- Respiratory tract infections
- Ulcerative colitis, Crohn's disease
- Type 1 diabetes (T1DM), insulin-dependent diabetes (IDDM)
- Type 1.5 diabetes, Latent autoimmune diabetes of adults (LADA)
Do you see yet why the medical establishment must SUPPRESS GcMAF and destroy all knowledge of its clinical applications? This one substance holds the potential to render numerous vaccines and pharmaceuticals utterly obsolete.
GcMAF protein described at NaturalHealth365.com:
Researchers and practitioners have demonstrated that GcMAF can reverse diseases that attack the immune system such as: chronic inflammation, bacterial and viral infections, chronic herpes, chronic acne, Lyme disease, fibromyalgia osteoporosis, Hodgkin's, Lupus, MS, Parkinson's and remarkably – autism.
A clinical study out of Italy on 94 children with autism showed that 83 of them made considerable progress while on GcMAF. The most common reported improvements involve:
• Cognitive abilities including attention and focus, learning and understanding, receptiveness and awareness of the environment and both receptive and expressive language gains.
• Social Skills including willingness to interact and communicate with peers.
• Behavior including less hyperactivity, less stereotypical behaviors and improved cooperation and compliance.
In another study of 1500 children with autism, 85% had high levels of viruses and a compromised immune system. All 1500 received weekly GcMAF injections and 70% of the children responded to the treatment with reduced symptoms and another 15% made full recoveries. The other 15% did not respond.
It was stated that the reduction of autistic symptoms is permanent provided that GcMAF has been taken long enough for the body to produce its own GcMAF which typically takes 24 weeks.